A carregar...

BRAF inhibition sensitizes melanoma cells to α-amanitin via decreased RNA polymerase II assembly

Despite the great success of small molecule inhibitors in the treatment of patients with BRAF(V600E) mutated melanoma, the response to these drugs remains transient and patients eventually relapse within a few months, highlighting the need to develop novel combination therapies based on the understa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Frischknecht, Lukas, Britschgi, Christian, Galliker, Patricia, Christinat, Yann, Vichalkovski, Anton, Gstaiger, Matthias, Kovacs, Werner J., Krek, Wilhelm
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6533289/
https://ncbi.nlm.nih.gov/pubmed/31123282
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-44112-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!